• Function: Standardized measure of Prothrombin Time (PT), assessing the extrinsic coagulation pathway (Factors II, V, VII, X).
  • Primary Use: Monitoring Warfarin (Coumadin) therapy.
    • Warfarin inhibits Vitamin K-dependent factors II, VII, IX, X.
  • Key INR Ranges:
    • Normal: ~1.0
    • Therapeutic Goal (most common): 2.0 - 3.0 for A-fib, DVT, PE.
    • Higher Goal: 2.5 - 3.5 for mechanical heart valves.
  • Factors that ↑ INR (↑ Bleeding Risk):
    • Drugs (CYP450 Inhibitors): Amiodarone, Metronidazole, Macrolides, Fluoroquinolones.
    • Liver Disease.
  • Factors that ↓ INR (↑ Clotting Risk):
    • Drugs (CYP450 Inducers): Rifampin, Phenytoin, Carbamazepine.
    • High Vitamin K Diet (leafy greens).
  • Reversal of High INR:
    • Minor Elevation: Hold warfarin.
    • Moderate/High Elevation (no bleed): Oral Vitamin K.
    • Serious Bleed: IV Vitamin K + Prothrombin Complex Concentrate (PCC) or FFP.